Bob Smith
InvestorVenture Partner at OrbiMed
About
Bob Smith joined OrbiMed in 2024 as a Venture Partner, bringing over thirty years of experience across alliance management, business development, commercial, M&A, and R&D roles. He retired from Pfizer in January 2024, where he led the company's global gene therapy business, its R&D business development activities, and strategic transactions team; he originally joined Pfizer in 2009 through its acquisition of Wyeth, where he led the global M&A group. He holds a B.S. in Neuroscience and an M.B.A. in Finance and Corporate Accounting from the University of Rochester.
Invests in
Biotech
Colleagues at OrbiMed
Frequently asked questions
- Who is Bob Smith?
- Bob Smith joined OrbiMed in 2024 as a Venture Partner, bringing over thirty years of experience across alliance management, business development, commercial, M&A, and R&D roles. He retired from Pfizer in January 2024, where he led the company's global gene therapy business, its R&D business development activities, and strategic transactions team; he originally joined Pfizer in 2009 through its acquisition of Wyeth, where he led the global M&A group. He holds a B.S. in Neuroscience and an M.B.A. in Finance and Corporate Accounting from the University of Rochester.
- Where does Bob Smith work?
- Bob Smith is Venture Partner at OrbiMed.
- What does Bob Smith invest in?
- Bob Smith invests in Biotech.